{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:46:47Z","timestamp":1787028407433,"version":"build-2736575974"},"reference-count":147,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T00:00:00Z","timestamp":1533859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Transforming growth factor (TGF)-\u03b2 signaling is not only important in skeletal development, but also essential in bone remodeling in adult bone. The bone remodeling process involves integrated cell activities induced by multiple stimuli to balance bone resorption and bone formation. TGF-\u03b2 plays a role in bone remodeling by coordinating cell activities to maintain bone homeostasis. However, mineral metabolism disturbance in chronic kidney disease (CKD) results in abnormal bone remodeling, which leads to ectopic calcification in CKD. High circulating levels of humoral factors such as parathyroid hormone, fibroblast growth factor 23, and Wnt inhibitors modulate bone remodeling in CKD. Several reports have revealed that TGF-\u03b2 is involved in the production and functions of these factors in bone. TGF-\u03b2 may act as a factor that mediates abnormal bone remodeling in CKD.<\/jats:p>","DOI":"10.3390\/ijms19082352","type":"journal-article","created":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T10:52:01Z","timestamp":1533898321000},"page":"2352","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["TGF-Beta Signaling in Bone with Chronic Kidney Disease"],"prefix":"10.3390","volume":"19","author":[{"given":"Yoshiko","family":"Iwasaki","sequence":"first","affiliation":[{"name":"Department of Health Sciences, Oita University of Nursing and Health Sciences, Oita 870-1163, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Yamato","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Metabolism, Tokai University School of Medicine, Kanagawa 259-119, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Fukagawa","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Metabolism, Tokai University School of Medicine, Kanagawa 259-119, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,8,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1677\/erc.1.01112","article-title":"The pleiotropic roles of transforming growth factor beta in homeostasis and carcinogenesis of endocrine organs","volume":"13","author":"Fleisch","year":"2006","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1242\/dev.104.2.263","article-title":"Embryonic expression pattern of TGF beta type-1 RNA suggests both paracrine and autocrine mechanisms of action","volume":"104","author":"Lehnert","year":"1988","journal-title":"Development"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S8756-3282(98)00080-5","article-title":"Expression and distribution of transforming growth factor-\u03b2 isoforms and their signaling receptors in growing human bone","volume":"23","author":"Horner","year":"1998","journal-title":"Bone"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bone.2015.04.035","article-title":"Bone development","volume":"80","author":"Berendsen","year":"2015","journal-title":"Bone"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"a008334","DOI":"10.1101\/cshperspect.a008334","article-title":"Development of the endochondral skeleton","volume":"5","author":"Long","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1210\/en.2005-0024","article-title":"A new selective estrogen receptor modulator with potent uterine antagonist activity, agonist activity in bone, and minimal ovarian stimulation","volume":"46","author":"Geiser","year":"2005","journal-title":"Endocrinology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00429-002-0273-6","article-title":"Tgf\u03b22\u2212\/\u2212 Tgf\u03b23\u2212\/\u2212 double knockout mice display severe midline fusion defects and early embryonic lethality","volume":"206","author":"Dunker","year":"2002","journal-title":"Anat. Embryol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1242\/dev.124.13.2659","article-title":"TGF beta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes","volume":"124","author":"Sanford","year":"1997","journal-title":"Development"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-4939-2966-5_18","article-title":"Role of TGF-\u03b2 signaling in coupling bone remodeling","volume":"1344","author":"Crane","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nm.1979","article-title":"TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation","volume":"15","author":"Tang","year":"2009","journal-title":"Nat. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1146\/annurev.cellbio.21.022404.142018","article-title":"Specificity and versatility in TGF-\u03b2 signaling through Smads","volume":"21","author":"Feng","year":"2005","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1359\/jbmr.1999.14.7.1145","article-title":"Localization of Smads, the TGF-\u03b2 family intracellular signaling components during endochondral ossification","volume":"14","author":"Sakou","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1083\/jcb.145.4.783","article-title":"Parathyroid hormone-related peptide (PTHrP)-dependent and -independent effects of transforming growth factor \u03b2 (TGF-\u03b2) on endochondral bone formation","volume":"145","author":"Serra","year":"1999","journal-title":"J. Cell Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2741\/1563","article-title":"TGF-\u03b2 signaling in chondrocytes","volume":"10","author":"Li","year":"2005","journal-title":"Front. Biosci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"6851","DOI":"10.1021\/bi00481a014","article-title":"The pro domain of pre-pro-transforming growth factor beta 1 when independently expressed is a functional binding protein for the mature growth factor","volume":"29","author":"Gentry","year":"1990","journal-title":"Biochemistry"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/316701a0","article-title":"Human transforming growth factor-\u03b2 complementary DNA sequence and expression in normal and transformed cells","volume":"316","author":"Derynck","year":"1985","journal-title":"Nature"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1083\/jcb.200608167","article-title":"Fibrillin-1 regulates the bioavailability of TGF\u03b21","volume":"176","author":"Chaudhry","year":"2007","journal-title":"J. Cell Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1083\/jcb.124.1.171","article-title":"Latent transforming growth factor-\u03b21 associates to fibroblast extracellular matrix via latent TGF-\u03b2 binding protein","volume":"124","author":"Taipale","year":"1994","journal-title":"J. Cell Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1083\/jcb.136.5.1151","article-title":"Latent transforming growth factor-\u03b2 binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-\u03b2","volume":"136","author":"Nunes","year":"1997","journal-title":"J. Cell Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1242\/jcs.114.1.187","article-title":"Latent TGF-\u03b2 binding protein LTBP-1 contains three potential extracellular matrix interacting domains","volume":"114","year":"2001","journal-title":"J. Cell Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1074\/jbc.M209256200","article-title":"Latent transforming growth factor \u03b2-binding protein 1 interacts with fibrillin and is a microfibril-associated protein","volume":"278","author":"Isogai","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"21352","DOI":"10.1074\/jbc.M111663200","article-title":"Proteolysis of latent transforming growth factor-\u03b2 (TGF-\u03b2)-binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-\u03b2 from bone matrix","volume":"277","author":"Dallas","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0006-291X(89)92795-2","article-title":"Activation of the bone-derived latent TGF \u03b2 complex by isolated osteoclasts","volume":"158","author":"Oreffo","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00441-011-1194-6","article-title":"Age-dependent alteration of TGF-\u03b2 signalling in osteoarthritis","volume":"347","author":"Goumans","year":"2012","journal-title":"Cell Tissue Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.cellsig.2014.01.021","article-title":"Canonical Wnt signaling skews TGF-\u03b2 signaling in chondrocytes towards signaling via ALK1 and Smad 1\/5\/8","volume":"26","author":"Blom","year":"2014","journal-title":"Cell. Signal."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/jcb.20773","article-title":"TGF-\u03b22 stimulates cranial suture closure through activation of the Erk-MAPK pathway","volume":"98","author":"Lee","year":"2006","journal-title":"J. Cell Biochem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"12197","DOI":"10.1074\/jbc.274.18.12197","article-title":"p57(Kip2) is degraded through the proteasome in osteoblasts stimulated to proliferation by transforming growth factor \u03b21","volume":"74","author":"Urano","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1359\/jbmr.2002.17.7.1190","article-title":"Smad3 promotes alkaline phosphatase activity and mineralization of osteoblastic MC3T3-E1 cells","volume":"17","author":"Sowa","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"F1471","DOI":"10.1152\/ajprenal.00485.2006","article-title":"TGF-\u03b2-activated kinase 1 and TAK1-binding protein 1 cooperate to mediate TGF-\u03b21-induced MKK3-p38 MAPK activation and stimulation of type I collagen","volume":"292","author":"Kim","year":"2007","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"15514","DOI":"10.1074\/jbc.M200794200","article-title":"Signal transductions induced by bone morphogenetic protein-2 and transforming growth factor-beta in normal human osteoblastic cells","volume":"277","author":"Lai","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/jcb.23079","article-title":"TGF-\u03b2 regulates \u03b2-catenin signaling and osteoblast differentiation in human mesenchymal stem cells","volume":"112","author":"Zhou","year":"2011","journal-title":"J. Cell Biochem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/pros.23489","article-title":"Osteoblast-derived factors promote metastatic potential in human prostate cancer cells, in part via non-canonical transforming growth factor \u03b2 (TGF\u03b2) signaling","volume":"78","author":"Karlsson","year":"2018","journal-title":"Prostate"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"7156","DOI":"10.1038\/sj.onc.1205937","article-title":"Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-\u03b2 and bone morphogenetic protein","volume":"21","author":"Lee","year":"2002","journal-title":"Oncogene"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0092-8674(00)80259-7","article-title":"Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development","volume":"89","author":"Otto","year":"1997","journal-title":"Cell"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0092-8674(01)00622-5","article-title":"The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation","volume":"108","author":"Nakashima","year":"2002","journal-title":"Cell"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nm1270","article-title":"NFAT and Osterix cooperatively regulate bone formation","volume":"11","author":"Koga","year":"2005","journal-title":"Nat. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1359\/jbmr.2000.15.7.1257","article-title":"Collagenase-3 (MMP-13) and integral membrane protein 2a (Itm2a) are marker genes of chondrogenic\/osteoblastic cells in bone formation: Sequential temporal, and spatial expression of Itm2a, alkaline phosphatase, MMP-13, and osteocalcin in the mouse","volume":"15","author":"Tuckermann","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1093\/emboj\/20.9.2254","article-title":"TGF-\u03b2-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation","volume":"20","author":"Alliston","year":"2001","journal-title":"EMBO J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"44061","DOI":"10.1074\/jbc.M207205200","article-title":"Matrix metalloproteinase-dependent activation of latent transforming growth factor-\u03b2 controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis","volume":"277","author":"Karsdal","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1359\/jbmr.2001.16.10.1754","article-title":"The loss of Smad 3 results in lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis","volume":"16","author":"Borton","year":"2001","journal-title":"J. Bone Miner. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1359\/jbmr.2001.16.7.1237","article-title":"Transforming growth factor-beta induces osteoclast ruffling and chemotaxis: Potential role in osteoclast recruitment","volume":"16","author":"Pilkington","year":"2001","journal-title":"J. Bone Miner. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/edrv.20.3.0367","article-title":"Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families","volume":"20","author":"Suda","year":"1999","journal-title":"Endocr. Rev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.tcb.2004.09.016","article-title":"CSF-1 regulation of the wandering macrophage: Complexity in action","volume":"4","author":"Pixley","year":"2004","journal-title":"Trends Cell Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.4049\/jimmunol.165.8.4254","article-title":"Endogenous production of TGF-\u03b2 is essential for osteoclastogenesis induced by a combination of receptor activator of NF-\u03baB ligand and macrophage-colony-stimulating factor","volume":"165","author":"Kaneda","year":"2000","journal-title":"J. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1006\/bbrc.1999.1632","article-title":"TGF-\u03b2 enhances osteoclast differentiation in hematopoietic cell cultures stimulated with RANKL and M-CSF","volume":"265","author":"Galvin","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1242\/jcs.113.13.2445","article-title":"A role for TGFbeta(1) in osteoclast differentiation and survival","volume":"113","author":"Fuller","year":"2000","journal-title":"J. Cell Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/jbmr.357","article-title":"Regulation of RANKL-induced osteoclastogenesis by TGF-\u03b2 through molecular interaction between Smad3 and Traf6","volume":"26","author":"Yasui","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Mohammad, K.S., Chen, C.G., Balooch, G., Stebbins, E., McKenna, C.R., Davis, H., Niewolna, M., Peng, X.H., Nguyen, D.H.N., and Ionova-Martin, S.S. (2009). Pharmacologic inhibition of the TGF-\u03b2 type I receptor kinase has anabolic and anti-catabolic effects on bone. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0005275"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/jcp.20036","article-title":"Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-\u03b2 regulation of osteoclast differentiation","volume":"200","author":"Karst","year":"2004","journal-title":"J. Cell Physiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1006\/bbrc.1998.9723","article-title":"Transforming growth factor-\u03b21 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic\/stromal cells and inhibits the survival of murine osteoclast-like cells","volume":"252","author":"Murakami","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"36241","DOI":"10.1074\/jbc.M104319200","article-title":"Stimulation of osteoprotegerin (OPG) gene expression by transforming growth factor-\u03b2 (TGF-\u03b2): Mapping of the OPG promoter region that mediates TGF-\u03b2 effects","volume":"276","author":"Thirunavukkarasu","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbrc.2009.12.171","article-title":"TGF\u03b2 inducible early gene-1 directly binds to, and represses, the OPG promoter in osteoblasts","volume":"392","author":"Subramaniam","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF01771319","article-title":"Isolated chick osteocytes stimulate formation and bone-resorbing activity of osteoclast-like cells","volume":"13","author":"Tanaka","year":"1995","journal-title":"J. Bone Miner. Metab."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4248\/ijos.09019","article-title":"Osteocyte remodeling of the perilacunar and pericanalicular matrix","volume":"1","author":"Qing","year":"2009","journal-title":"Int. J. Oral Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/jbmr.2003","article-title":"Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2","volume":"28","author":"Kogawa","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/jbmr.1567","article-title":"Demonstration of osteocytic perilacunar\/canalicular remodeling in mice during lactation","volume":"27","author":"Qing","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bone.2013.01.025","article-title":"Osteocytes remove and replace perilacunar mineral during reproductive cycles","volume":"54","author":"Wysolmerski","year":"2013","journal-title":"Bone"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/cbf.1529","article-title":"TGF \u03b23 and loading increases osteocyte survival in human cancellous bone cultured ex vivo","volume":"27","author":"Simpson","year":"2009","journal-title":"Cell Biochem. Funct."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1359\/jbmr.2002.17.5.907","article-title":"Spatial distribution of Bax and Bcl-2 in osteocytes after bone fatigue: Complementary roles in bone remodeling regulation?","volume":"17","author":"Verborgt","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.cmet.2007.05.001","article-title":"Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction","volume":"5","author":"Tatsumi","year":"2007","journal-title":"Cell Metab."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO). Definition, evaluation, and classification of renal osteodystrophy: A position statement from kidney disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.2215\/CJN.08241109","article-title":"Fibroblast growth factor-23 in early chronic kidney disease: Additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism","volume":"5","author":"Evenepoel","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/jbmr.1916","article-title":"Rapid cortical bone loss in patients with chronic kidney disease","volume":"28","author":"Nickolas","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s001980050089","article-title":"Volumetric bone density and geometry assessed by peripheral quantitative computed tomography in uremic patients on maintenance hemodialysis","volume":"8","author":"Russo","year":"1998","journal-title":"Osteoporos. Int."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5414\/CN109006","article-title":"HR-pQCT detects alterations in bone microstructure in men with CKD stages 3 and 4, which are influenced by hormonal changes and body composition","volume":"89","author":"Lima","year":"2018","journal-title":"Clin. Nephrol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1053\/ajkd.2001.27426","article-title":"Skeletal resistance to PTH as a basic abnormality underlying uremic bone disease","volume":"38","author":"Fukagawa","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1038\/sj.ki.5001600","article-title":"Insufficiency of PTH action on bone in uremia","volume":"70","author":"Iwasaki","year":"2006","journal-title":"Kidney Int."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.semnephrol.2014.09.008","article-title":"Adynamic bone disease: From bone to vessels in chronic kidney disease","volume":"34","author":"Bover","year":"2014","journal-title":"Semin. Nephrol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1681\/ASN.2007010022","article-title":"Fracture risk after parathyroidectomy among chronic kidney disease","volume":"18","author":"Rudser","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/ndt\/gfu055","article-title":"A higher serum alkaline phosphatase is associated with the incidence of hip fracture and mortality among patients receiving hemodialysis in Japan","volume":"29","author":"Maruyama","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0272-6386(99)70302-1","article-title":"Risk factors for vertebral fracture in renal osteodystrophy","volume":"33","author":"Atsumi","year":"1999","journal-title":"Am. J. Kidney Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.bone.2011.03.672","article-title":"Changes in chemical composition of cortical bone associated with bone fragility in rat model with chronic kidney disease","volume":"48","author":"Iwasaki","year":"2011","journal-title":"Bone"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00467-015-3069-7","article-title":"From skeletal to cardiovascular disease in 12 steps-the evolution of sclerostin as a major player in CKD-MBD","volume":"31","author":"Brandenburg","year":"2016","journal-title":"Pediatr. Nephrol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000353569","article-title":"Effects of phosphate binder therapy on vascular stiffness in early-stage chronic kidney disease","volume":"38","author":"Seifert","year":"2013","journal-title":"Am. J. Nephrol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"i37","DOI":"10.1093\/ndt\/gft267","article-title":"Transforming growth factor-\u03b2 and the progression of renal disease","volume":"29","author":"Loeffler","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/ki.2009.66","article-title":"Circulating transforming growth factor-\u03b21 levels and the risk for kidney disease in African Americans","volume":"76","author":"Seifert","year":"2009","journal-title":"Kidney Int."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2362.2006.01663.x","article-title":"Function and effect of bone morphogenetic protein-7 in kidney bone and the bone-vascular links in chronic kidney disease","volume":"36","author":"Mathew","year":"2006","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/08860229809045096","article-title":"Metabolism of transforming growth factor-beta in patients receiving hemodialysis especially those with renal osteodystrophy","volume":"20","author":"Jiang","year":"1998","journal-title":"Ren. Fail."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1590\/S0100-879X2002000100004","article-title":"Cytokine accumulation in osteitis fibrosa of renal osteodystrophy","volume":"35","author":"Duarte","year":"2002","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.1523-1755.2003.00835.x","article-title":"IL-1beta, TNF-alpha, TGF-beta, and bFGF expression in bone biopsies before and after parathyroidectomy","volume":"63","author":"Santos","year":"2003","journal-title":"Kidney Int."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1046\/j.1523-1755.1999.07312.x","article-title":"Cellular mechanisms of renal osteodystrophy","volume":"56","author":"Hoyland","year":"1999","journal-title":"Kidney Int."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/mp.50.3.132","article-title":"Apoptosis in bone physiology and disease","volume":"50","author":"Hughes","year":"1997","journal-title":"Mol. Pathol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/jbmr.2120","article-title":"Role of TGF-\u03b2 in a mouse model of high turnover renal osteodystrophy","volume":"29","author":"Liu","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1210\/me.2009-0379","article-title":"Novel links among Wnt and TGF-\u03b2 signaling and Runx2","volume":"24","author":"McCarthy","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"357","DOI":"10.7326\/0003-4819-78-3-357","article-title":"Skeletal resistance to parathyroid hormone in renal failure. Study in 105 human subjects","volume":"78","author":"Massry","year":"1973","journal-title":"Ann. Intern. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ki.1991.314","article-title":"Calcemic response to parathyroid hormone in renal failure: Role of phosphorus and its effect on calcitriol","volume":"40","author":"Rodriguez","year":"1991","journal-title":"Kidney Int."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ki.1994.276","article-title":"The calcemic response to PTH in the rat: Effect of elevated PTH levels and uremia","volume":"46","author":"Bover","year":"1994","journal-title":"Kidney Int."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/ki.1991.315","article-title":"Calcemic response to parathyroid hormone in renal failure: Role of calcitriol and the effect parathyroidectomy","volume":"40","author":"Rodriguez","year":"1991","journal-title":"Kidney Int."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/ki.1994.79","article-title":"The renal PTH\/PTHrP receptor is downregulated in rats with chronic renal failure","volume":"45","author":"Urena","year":"1994","journal-title":"Kidney Int."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1038\/ki.1995.248","article-title":"Parathyroidectomy does not prevent the renal PTH\/PTHrP receptor down regulation in uremic rats","volume":"47","author":"Urena","year":"1995","journal-title":"Kidney Int."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1210\/endo.136.8.7628359","article-title":"Down-regulation of the receptor for parathyroid hormone (PTH) and PTH-related peptide by transforming growth factor-beta in primary fetal rat osteoblasts","volume":"136","author":"Jongen","year":"1995","journal-title":"Endocrinology"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/ncb2022","article-title":"TGF-beta type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling","volume":"12","author":"Qiu","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/sj.ki.5002097","article-title":"Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells","volume":"71","author":"Iwasaki","year":"2007","journal-title":"Kidney Int."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bone.2013.07.002","article-title":"p-Cresyl sulfate induces osteoblast dysfunction through activating JNK and p38 MAPK pathways","volume":"56","author":"Tanaka","year":"2013","journal-title":"Bone"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1093\/ndt\/gfm455","article-title":"The uraemic toxin phenylacetic acid inhibits osteoblastic proliferation and differentiation: An implication for the pathogenesis of low turnover bone in chronic renal failure","volume":"22","author":"Yano","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1093\/ndt\/gfm347","article-title":"Regulation of fibroblast growth factor-23 in chronic kidney disease","volume":"22","author":"Westerberg","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Chronic Renal Insufficiency Cohort (CRIC) Study Group. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"F882","DOI":"10.1152\/ajprenal.00360.2010","article-title":"PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: A bone parathyroid feedback loop","volume":"299","author":"Wasserman","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1038\/s41598-017-05226-y","article-title":"The production of fibroblast growth factor 23 is controlled by TGF-\u03b22","volume":"7","author":"Feger","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/ndt\/gfr384","article-title":"Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism","volume":"27","author":"Koizumi","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-physiol-030212-183727","article-title":"Fibroblast growth factor 23 and Klotho: Physiology and pathophysiology of an endocrine network of mineral metabolism","volume":"75","author":"Hu","year":"2013","journal-title":"Annu. Rev. Physiol."},{"key":"ref_104","first-page":"4003","article-title":"The parathyroid is a target organ for FGF23 in rats","volume":"117","author":"Galitzer","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/ki.2009.464","article-title":"Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease","volume":"77","author":"Galitzer","year":"2010","journal-title":"Kidney Int."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1681\/ASN.2009040427","article-title":"FGF23 fails to inhibit uremic parathyroid glands","volume":"21","author":"Canalejo","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/ki.2009.414","article-title":"Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients","volume":"77","author":"Komaba","year":"2010","journal-title":"Kidney Int."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/ki.2010.328","article-title":"Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective","volume":"78","author":"Hu","year":"2010","journal-title":"Kidney Int."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/ki.2014.215","article-title":"Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription","volume":"86","author":"Meir","year":"2014","journal-title":"Kidney Int."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00223-012-9683-5","article-title":"1,25-dihydroxyvitamin D-3 regulation of fibroblast growth factor-23 expression in bone cells: Evidence for primary and secondary mechanisms modulated by leptin and interleukin-6","volume":"92","author":"Saini","year":"2013","journal-title":"Calcif. Tissue Int."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00109-015-1370-3","article-title":"NF\u03baB-sensitive Orai1 expression in the regulation of FGF23 release","volume":"94","author":"Zhang","year":"2016","journal-title":"J. Mol. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.kint.2017.01.015","article-title":"Kidney fibroblast growth factor 23 does not contribute to elevation of its circulating levels in uremia","volume":"92","author":"Mace","year":"2017","journal-title":"Kidney Int."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.biocel.2017.09.009","article-title":"FGF23 activates injury-primed renal fibroblasts via FGFR4-dependent signalling and enhancement of TGF-\u03b2 autoinduction","volume":"92","author":"Smith","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.kint.2017.02.014","article-title":"Klotho expression in osteocytes regulates bone metabolism and controls bone formation","volume":"92","author":"Komaba","year":"2017","journal-title":"Kidney Int."},{"key":"ref_115","first-page":"519","article-title":"Fibroblast growth factor receptor 4 (FGFR4) expression in newborn murine calvaria and primary osteoblast cultures","volume":"46","author":"Cool","year":"2002","journal-title":"Int. J. Dev. Biol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1136\/annrheumdis-2013-204378","article-title":"Vitamin D receptor regulates TGF-\u03b2 signalling in systemic sclerosis","volume":"74","author":"Zerr","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/ndt\/gfr270","article-title":"Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients","volume":"27","author":"Cejka","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00223-012-9595-4","article-title":"Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): Relationship with bone density and arterial stiffness","volume":"90","author":"Thambiah","year":"2012","journal-title":"Calcif. Tissue Int."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/jbmr.1630","article-title":"Repression of osteocyte Wnt\/\u03b2-catenin signaling is an early event in the progression of renal osteodystrophy","volume":"27","author":"Sabbagh","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1093\/ndt\/gft234","article-title":"Disturbances of Wnt\/\u03b2-catenin pathway and energy metabolism in early CKD: Effect of phosphate binders","volume":"28","author":"Graciolli","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.kint.2016.12.029","article-title":"The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease","volume":"91","author":"Graciolli","year":"2017","journal-title":"Kidney Int."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jbmr.217","article-title":"Relation of age, gender, and bone mass to circulating sclerostin levels in women and men","volume":"26","author":"Hoey","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1210\/jc.2014-2372","article-title":"Relationship between serum sclerostin, bone metabolism markers, and bone mineral density in maintenance hemodialysis patients","volume":"99","author":"Ishimura","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/ki.2014.372","article-title":"Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease","volume":"87","author":"Barreto","year":"2015","journal-title":"Kidney Int."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2215\/CJN.06550810","article-title":"Sclerostin and Dickkopf-1 in renal osteodystrophy","volume":"6","author":"Cejka","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1093\/ndt\/gft039","article-title":"Sclerostin: Another bone-related protein related to all-cause mortality in haemodialysis?","volume":"28","author":"Viaene","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2005.03.018","article-title":"SOST is a target gene for PTH in bone","volume":"37","author":"Keller","year":"2005","journal-title":"Bone"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1359\/jbmr.070804","article-title":"Control of the SOST bone enhancer by PTH using MEF2 transcription factors","volume":"22","author":"Leupin","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.bone.2011.11.016","article-title":"TGF-\u03b2 regulates sclerostin expression via the ECR5 enhancer","volume":"50","author":"Loots","year":"2012","journal-title":"Bone"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s00223-017-0243-x","article-title":"Advanced glycation end product 3 (AGE3) increases apoptosis and the expression of sclerostin by stimulating TGF-\u03b2 expression and secretion in osteocyte-like MLO-Y4-A2 cells","volume":"100","author":"Notsu","year":"2017","journal-title":"Calcif. Tissue Int."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/ki.1997.160","article-title":"Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure","volume":"51","author":"Miyata","year":"1997","journal-title":"Kidney Int."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.3074","article-title":"WNT signaling in bone homeostasis and disease: From human mutations to treatments","volume":"19","author":"Baron","year":"2013","journal-title":"Nat. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1210\/er.2011-1060","article-title":"Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases","volume":"33","author":"Ke","year":"2012","journal-title":"Endocr. Rev."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1359\/jbmr.090730","article-title":"Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient mice","volume":"25","author":"Kramer","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"E81","DOI":"10.1210\/jc.2013-3249","article-title":"Effects of estrogen on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in postmenopausal women","volume":"99","author":"Fujita","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"E60","DOI":"10.1210\/jc.2012-3038","article-title":"Plasma Dickkopf1 (DKK1) concentrations negatively associate with atherosclerotic calcified plaque in African-Americans with type 2 diabetes","volume":"98","author":"Register","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1210\/jc.2013-3201","article-title":"Severe abdominal aortic calcification in older men is negatively associated with DKK1 serum levels: The STRAMBO study","volume":"99","author":"Szulc","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bone.2013.05.010","article-title":"The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women","volume":"56","author":"Hampson","year":"2013","journal-title":"Bone"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1681\/ASN.2013080818","article-title":"CKD-induced wingless\/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder","volume":"25","author":"Fang","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Lindberg, K., Olauson, H., Amin, R., Ponnusamy, A., Goetz, R., Taylor, R.F., Mohammadi, M., Canfield, A., Kublickiene, K., and Larsson, T.E. (2013). Arterial klotho expression and FGF23 effects on vascular calcification and function. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0060658"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.kint.2016.02.002","article-title":"Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease","volume":"89","author":"Agapova","year":"2016","journal-title":"Kidney Int."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1359-6101(01)00010-7","article-title":"The role of the activin-follistatin system in the developmental and regeneration processes of the kidney","volume":"12","author":"Maeshima","year":"2001","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1210\/edrv-9-2-267","article-title":"Inhibins, activins, and follistatins: Gonadal proteins modulating the secretion of follicle-stimulating hormone","volume":"9","author":"Ying","year":"1988","journal-title":"Endocr. Rev."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.kint.2016.07.039","article-title":"Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease","volume":"91","author":"Sugatani","year":"2017","journal-title":"Kidney Int."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.kint.2017.06.016","article-title":"The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease","volume":"93","author":"Williams","year":"2018","journal-title":"Kidney Int."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.kint.2016.01.024","article-title":"Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease","volume":"90","author":"Panizo","year":"2016","journal-title":"Kidney Int."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jbmr.2606","article-title":"FGF23 regulates bone mineralization in a 1,25(OH)2D3 and Klotho-independent manner","volume":"31","author":"Murali","year":"2016","journal-title":"J. Bone Miner. Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/8\/2352\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:17:51Z","timestamp":1760195871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/8\/2352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,10]]},"references-count":147,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8]]}},"alternative-id":["ijms19082352"],"URL":"https:\/\/doi.org\/10.3390\/ijms19082352","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,10]]}}}